Bioventix PLC
F:51B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Bioventix PLC (51B) under the Base Case is EUR per share.
Compared with the current market price of 23.2 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Bioventix Does
Bioventix makes specialist antibodies that help medical test makers detect tiny amounts of substances in blood. Its main products are sheep-derived monoclonal antibodies used in diagnostic kits for hormones, heart markers, and other clinical tests. The company does not sell tests directly to hospitals; it sells the key biological ingredient that test manufacturers build into their own assays.
- Headquarters
- United Kingdom UK
- Employees
- 12
- IPO date
- Apr 29, 2014
Continue 51B Research
Decided on Bioventix? Get an email when 51B reaches the price you’d buy at. Free with an account.
Other Bioventix listings
What is the Intrinsic Value of one 51B stock?
The intrinsic value for
Bioventix PLC (51B) under the Base Case is EUR.
Is 51B stock undervalued or overvalued?
Compared with the current market price of 23.2 EUR, the stock appears .